We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TDUP:NASDAQThredUp Inc. Analysis

Data as of 2026-09-10 - not real-time

$2.70

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind ThredUp Inc. is bearish at $2.70, with short-term averages lagging the long-term ones. The last 30 days have lost 54.2%. With RSI at 30.9 the momentum picture is approaching oversold, alongside a bullish MACD signal. The recent range runs from support at $2.48 up to resistance at $3.21.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 168.1% above the current price. Revenue is growing at 16.9% on a -6.7% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 210.2%, a beta of 2.22 and a maximum drawdown of 76.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

On August 5, ThredUp Inc. NASDAQ:TDUP updated its full-year financial guidance alongside its second-quarter 2026...On August 5, ThredUp Inc. NASDAQ:TDUP updated its full-year financial guidance alongside its second-quarter 2026...Record quarterly revenue of $90.8 million, representing an increase of 17% year-over-yearQuarterly gross margin of...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 5.04
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 5.04
  • Analyst targets imply +168.1% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -6.7%
  • Analyst targets imply +168.1% versus the current price
  • Negative return on equity of -36.8%

Key Metrics & Analysis

Financial Health

Revenue Growth16.90%
Profit Margin-6.65%
P/E Ratio-22.0
ROE-36.76%
ROA-8.25%
Debt/Equity83.31
P/B Ratio5.8
Op. Cash Flow$13.8M
Free Cash Flow$12.9M

Technical Analysis

TrendBearish
RSI30.9
Support$2.48
Resistance$3.21
MA 20$2.79
MA 50$4.68
MA 200$5.04
MACDBullish
VolumeDecreasing
Fear & Greed Index91.68

Valuation

Fair Value$2.49
Target Price$7.24
Upside/Downside168.15%
GradeFair
TypeGrowth

Risk Assessment

Beta2.22
Volatility210.17%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.